SCHEMBL2932705

SCHEMBL2932705

CC(=O)N(CC(=O)O)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634109 0.98
Fluoride Ion SCHEMBL28198003 0.93
SCHEMBL22749800 0.79
SCHEMBL9463026 0.78 L3MBTL1 (0.47)
SCHEMBL7386062 0.78
SCHEMBL4159697 0.77 EPHX2 (0.40)
SCHEMBL9728254 0.77 PIK3CD (0.42)
SCHEMBL658992 0.77 L3MBTL1 (0.50)
SCHEMBL18513375 0.77 PIK3CD (0.42)
SCHEMBL7416818 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229399-A1 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF Provid Pharmaceuticals, Inc. (US) 2010-09-22 EP disclosed
WO-2009073168-A1 INHIBITORS OF ANTIGEN PRESENTATION BY MHC CLASS II MOLECULES AND METHODS OF USE THEREOF PROVID PHARMACEUTICALS, INC. (US) 2009-06-11 WO disclosed
US-6740647-B1 AMIDINES AND HYDROXYAMIDINE DERIVATIVES ABBOTT GMBH & CO., KG (DE) 2004-05-25 US disclosed
EP-1051431-A1 THROMBIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2000-11-15 EP disclosed
EP-1049673-A1 HETEROCYCLIC AMIDINES AS CALLICREIN PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2000-11-08 EP disclosed
WO-1999037668-A1 THROMBIN INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-07-29 WO disclosed
WO-1999037611-A1 HETEROCYCLIC AMIDINES AS CALLICREIN PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-07-29 WO disclosed